HK1220412A1 - 改良的細胞外基質組合物的製作方法 - Google Patents
改良的細胞外基質組合物的製作方法Info
- Publication number
- HK1220412A1 HK1220412A1 HK16108378.7A HK16108378A HK1220412A1 HK 1220412 A1 HK1220412 A1 HK 1220412A1 HK 16108378 A HK16108378 A HK 16108378A HK 1220412 A1 HK1220412 A1 HK 1220412A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- extracellular matrix
- improved method
- matrix compositions
- making extracellular
- making
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/3604—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
- A61L27/3633—Extracellular matrix [ECM]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/3641—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the site of application in the body
- A61L27/3645—Connective tissue
- A61L27/3662—Ligaments, tendons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/3641—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the site of application in the body
- A61L27/3675—Nerve tissue, e.g. brain, spinal cord, nerves, dura mater
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/3683—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment
- A61L27/3687—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment characterised by the use of chemical agents in the treatment, e.g. specific enzymes, detergents, capping agents, crosslinkers, anticalcification agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/3683—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment
- A61L27/3691—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment characterised by physical conditions of the treatment, e.g. applying a compressive force to the composition, pressure cycles, ultrasonic/sonication or microwave treatment, lyophilisation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
- A61L27/3804—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
- A61L27/3834—Cells able to produce different cell types, e.g. hematopoietic stem cells, mesenchymal stem cells, marrow stromal cells, embryonic stem cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/416—Anti-neoplastic or anti-proliferative or anti-restenosis or anti-angiogenic agents, e.g. paclitaxel, sirolimus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2430/00—Materials or treatment for tissue regeneration
- A61L2430/10—Materials or treatment for tissue regeneration for reconstruction of tendons or ligaments
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2430/00—Materials or treatment for tissue regeneration
- A61L2430/32—Materials or treatment for tissue regeneration for nerve reconstruction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2430/00—Materials or treatment for tissue regeneration
- A61L2430/38—Materials or treatment for tissue regeneration for reconstruction of the spine, vertebrae or intervertebral discs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2430/00—Materials or treatment for tissue regeneration
- A61L2430/40—Preparation and treatment of biological tissue for implantation, e.g. decellularisation, cross-linking
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Botany (AREA)
- General Health & Medical Sciences (AREA)
- Dermatology (AREA)
- Medicinal Chemistry (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Transplantation (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Urology & Nephrology (AREA)
- Cell Biology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Vascular Medicine (AREA)
- Biophysics (AREA)
- General Chemical & Material Sciences (AREA)
- Developmental Biology & Embryology (AREA)
- Hematology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Rehabilitation Therapy (AREA)
- Rheumatology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201361800532P | 2013-03-15 | 2013-03-15 | |
PCT/US2014/027102 WO2014152234A1 (fr) | 2013-03-15 | 2014-03-14 | Procédé amélioré de fabrication de compositions de matrice extracellulaire |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1220412A1 true HK1220412A1 (zh) | 2017-05-05 |
Family
ID=51581155
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK16108378.7A HK1220412A1 (zh) | 2013-03-15 | 2016-07-15 | 改良的細胞外基質組合物的製作方法 |
Country Status (7)
Country | Link |
---|---|
US (1) | US20160030635A1 (fr) |
EP (2) | EP2968679B1 (fr) |
DK (1) | DK2968679T3 (fr) |
ES (1) | ES2667954T3 (fr) |
HK (1) | HK1220412A1 (fr) |
NO (1) | NO2975611T3 (fr) |
WO (1) | WO2014152234A1 (fr) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20150037436A1 (en) | 2013-07-30 | 2015-02-05 | Musculoskeletal Transplant Foundation | Acellular soft tissue-derived matrices and methods for preparing same |
WO2019231860A1 (fr) * | 2018-05-27 | 2019-12-05 | The Board Of Trustees Of The Leland Stanford Junior University | Procédé de traitement ou de prévention de la mucosite orale associée à une radiothérapie et à une chimiothérapie utilisant un facteur de croissance de type facteur de croissance épidermique se liant à l'héparine (hb-egf) administré par voie locale |
KR101782005B1 (ko) | 2015-05-28 | 2017-09-27 | 한국과학기술원 | 암미세환경 어레이 플랫폼 |
WO2016193991A1 (fr) * | 2015-06-05 | 2016-12-08 | Soma Guhathakurta | Échafaudage pour la régénération de la cornée |
US10912864B2 (en) | 2015-07-24 | 2021-02-09 | Musculoskeletal Transplant Foundation | Acellular soft tissue-derived matrices and methods for preparing same |
US11052175B2 (en) | 2015-08-19 | 2021-07-06 | Musculoskeletal Transplant Foundation | Cartilage-derived implants and methods of making and using same |
US10624931B2 (en) | 2015-09-23 | 2020-04-21 | Osiris Therapeutics, Inc. | Umbilical tissue compositions and methods of use |
WO2017059089A1 (fr) * | 2015-09-29 | 2017-04-06 | Anicell Biotech, Llc | Méthodes et articles manufacturés pour le traitement d'animaux |
US11318168B2 (en) | 2016-06-24 | 2022-05-03 | Osiris Therapeutics, Inc. | Human tissue derived compositions and uses thereof |
WO2018067938A1 (fr) * | 2016-10-06 | 2018-04-12 | The Trustees Of Columbia University In The City Of New York | Agent d'étanchéité hydrogel pour poumon poreux ensemencé de cellules |
GB2555787A (en) | 2016-11-07 | 2018-05-16 | Landberg Goran | Diagnostic methods |
KR101959300B1 (ko) * | 2017-05-02 | 2019-03-18 | 엘지전자 주식회사 | 차량용 스마트 키 및 시스템 |
WO2019021320A2 (fr) * | 2017-07-27 | 2019-01-31 | Dr Habeebullah Life Sciences Limited | Conduit neuronal pour reconstituer et régénérer un système nerveux dégénéré ou endommagé |
WO2019136021A1 (fr) * | 2018-01-03 | 2019-07-11 | Sakkos Jonathan Konstantine | Ensemble biologique comprenant un composant biologique et une protection |
US20210198634A1 (en) * | 2018-09-04 | 2021-07-01 | Beth Israel Deaconess Medical Center, Inc. | Methods of culturing podocytes and compositions thereof |
US20220002360A1 (en) * | 2018-09-28 | 2022-01-06 | Smsbiotech, Inc. | Extracellular matrix protein compositions and methods for treating wounds |
WO2020201488A1 (fr) | 2019-04-04 | 2020-10-08 | Hackethal Johannes | Nouvelle technologie de plate-forme basée sur un matériau humain pour ingénierie tissulaire |
EP4149491A4 (fr) * | 2020-05-15 | 2023-11-15 | Mayo Foundation for Medical Education and Research | Hydrogels nanocomposites dérivés de tissu bioactif pour embolisation artérielle permanente et cicatrisation vasculaire améliorée |
US20240024371A1 (en) * | 2020-12-04 | 2024-01-25 | Sdf Biopharma Inc. | Treating diabetes |
Family Cites Families (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3157524A (en) | 1960-10-25 | 1964-11-17 | Ethicon Inc | Preparation of collagen sponge |
US3800792A (en) | 1972-04-17 | 1974-04-02 | Johnson & Johnson | Laminated collagen film dressing |
US4185011A (en) | 1978-10-16 | 1980-01-22 | Firma Carl Freudenberg | Process for the production of collagen fibers |
DE2943520C2 (de) | 1979-10-27 | 1982-05-19 | Fa. Carl Freudenberg, 6940 Weinheim | Verfahren zur Herstellung von Kollagenschwamm für medizinische oder kosmetische Zwecke |
DE3042860A1 (de) | 1980-11-13 | 1982-06-09 | Heyl & Co Chemisch-Pharmazeutische Fabrik, 1000 Berlin | Kollagenpraeparate, verfahren zu ihrer herstellung und ihre verwendung in der human- und veterinaermedizin |
FR2516927B1 (fr) | 1981-11-26 | 1986-05-23 | Merieux Fond | Procede de preparation industrielle de materiaux collageniques a partir de tissus placentaires humains, materiaux collageniques humains obtenus, leur application comme biomateriaux |
US4582640A (en) | 1982-03-08 | 1986-04-15 | Collagen Corporation | Injectable cross-linked collagen implant material |
US4837285A (en) | 1984-03-27 | 1989-06-06 | Medimatrix | Collagen matrix beads for soft tissue repair |
US4642117A (en) | 1985-03-22 | 1987-02-10 | Collagen Corporation | Mechanically sheared collagen implant material and method |
US5436135A (en) | 1985-09-02 | 1995-07-25 | Pasteur Merieux Serums Et Vaccins | New preparation of placenta collagen, their extraction method and their applications |
US4852640A (en) | 1986-03-28 | 1989-08-01 | Exothermics-Eclipse Inc. | Recuperative heat exchanger |
US5660692A (en) | 1988-02-24 | 1997-08-26 | Cedars-Sinai Medical Center | Method of crosslinking amino acid-containing polymers using photoactivatable chemical crosslinkers |
US5008116A (en) | 1988-11-14 | 1991-04-16 | Frederick Cahn | Immunostimulatory microsphere |
US5116620A (en) | 1989-11-21 | 1992-05-26 | Bruce A. Barber | Antimicrobial wound dressing |
US5336616A (en) * | 1990-09-12 | 1994-08-09 | Lifecell Corporation | Method for processing and preserving collagen-based tissues for transplantation |
FR2692582B1 (fr) | 1992-06-18 | 1998-09-18 | Flamel Tech Sa | Nouveaux derives reticulables de collagene, leur procede d'obtention et leur application a la preparation de biomateriaux. |
US5428022A (en) | 1992-07-29 | 1995-06-27 | Collagen Corporation | Composition of low type III content human placental collagen |
FR2699184B1 (fr) | 1992-12-16 | 1995-03-10 | Flamel Tech Sa | Nouveaux dérivés de collagène, leur procédé d'obtention et leur application à la préparation de biomatériaux. |
EP0888142B1 (fr) | 1996-03-04 | 2003-05-28 | Edwards Lifesciences Corporation | Composes epoxy non polymeres destines a la reticulation de tissus biologiques et greffons pour bioprotheses ainsi obtenus |
US5814328A (en) | 1997-01-13 | 1998-09-29 | Gunasekaran; Subramanian | Preparation of collagen using papain and a reducing agent |
US6117979A (en) | 1997-08-18 | 2000-09-12 | Medtronic, Inc. | Process for making a bioprosthetic device and implants produced therefrom |
ES2522890T3 (es) | 2000-12-06 | 2014-11-19 | Anthrogenesis Corporation | Método para recolectar células troncales placentarias |
NZ527849A (en) | 2001-02-14 | 2006-09-29 | Anthrogenesis Corp | Post-partum mammalian placenta, its use and placental stem cells therefrom |
WO2003020031A1 (fr) | 2001-08-31 | 2003-03-13 | University Of Southern California | Utilisation de reactifs de reticulation non toxiques destinee a l'amelioration de la resistance a la fatigue et a la diminution de la degradation mecanique d'un disque intervertebral et d'autres tissus collagenes |
US20030187515A1 (en) | 2002-03-26 | 2003-10-02 | Hariri Robert J. | Collagen biofabric and methods of preparing and using the collagen biofabric |
US20050013870A1 (en) * | 2003-07-17 | 2005-01-20 | Toby Freyman | Decellularized extracellular matrix of conditioned body tissues and uses thereof |
KR20190104428A (ko) | 2005-12-29 | 2019-09-09 | 안트로제네시스 코포레이션 | 태반 줄기 세포 집단 |
MX354253B (es) * | 2006-10-06 | 2018-02-20 | Anthrogenesis Corp | Composiciones de colageno placentario (telopeptido), natural. |
RU2562154C2 (ru) | 2008-11-19 | 2015-09-10 | Антродженезис Корпорейшн | Амниотические адгезивные клетки |
US20110165676A1 (en) * | 2009-11-06 | 2011-07-07 | The Children's Mercy Hospital | Method for decellularization |
US9623051B2 (en) * | 2011-04-15 | 2017-04-18 | The Regents Of The University Of California | Decellularized extracellular matrix |
WO2013009595A2 (fr) * | 2011-07-08 | 2013-01-17 | University Of Pittsburgh - Of The Commonwealth System Of Higher Education | Matrice extracellulaire (ecm) dérivée du système nerveux central (cns), injectable pour une reconstruction tissulaire |
-
2011
- 2011-09-14 NO NO15183624A patent/NO2975611T3/no unknown
-
2014
- 2014-03-14 WO PCT/US2014/027102 patent/WO2014152234A1/fr active Application Filing
- 2014-03-14 DK DK14771007.3T patent/DK2968679T3/en active
- 2014-03-14 EP EP14771007.3A patent/EP2968679B1/fr active Active
- 2014-03-14 EP EP17204887.8A patent/EP3360585A1/fr not_active Withdrawn
- 2014-03-14 US US14/775,875 patent/US20160030635A1/en not_active Abandoned
- 2014-03-14 ES ES14771007.3T patent/ES2667954T3/es active Active
-
2016
- 2016-07-15 HK HK16108378.7A patent/HK1220412A1/zh unknown
Also Published As
Publication number | Publication date |
---|---|
EP3360585A1 (fr) | 2018-08-15 |
EP2968679A4 (fr) | 2016-11-23 |
NO2975611T3 (fr) | 2018-06-09 |
US20160030635A1 (en) | 2016-02-04 |
EP2968679B1 (fr) | 2018-01-10 |
WO2014152234A1 (fr) | 2014-09-25 |
DK2968679T3 (en) | 2018-04-23 |
ES2667954T3 (es) | 2018-05-16 |
EP2968679A1 (fr) | 2016-01-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1220412A1 (zh) | 改良的細胞外基質組合物的製作方法 | |
GB201304662D0 (en) | Compositions | |
GB201401248D0 (en) | Method of manufacture | |
GB201316450D0 (en) | Method of preparing edible composition | |
GB201313615D0 (en) | Compositions | |
GB201507664D0 (en) | Composition & methods of screening | |
EP2917314A4 (fr) | Composition d'oligomère | |
IL243829A0 (en) | Production method for saline preparation | |
GB201319531D0 (en) | Composition & methods of screening | |
GB201317105D0 (en) | Novel Composition | |
EP2808376A4 (fr) | Procédé de production d'une composition | |
EP2998395A4 (fr) | Procédé d'obtention de composition contenant une lactase | |
PT2947996T (pt) | Método para produzir composições de beta-caseína e produtos relacionados | |
GB201305231D0 (en) | Method of Manufacture | |
GB201316463D0 (en) | Novel compositions | |
ZA201505650B (en) | New compositions | |
HRP20182110T1 (hr) | Sastav spojeva tiakumicina | |
GB201319923D0 (en) | Novel composition | |
GB201310513D0 (en) | Novel composition | |
GB201320962D0 (en) | Compositions | |
ZA201509070B (en) | Method of making detergent compositions comprosing polymers | |
HK1204865A1 (en) | Composition for elimination of troublesome varmints | |
KR102216470B9 (ko) | 천연물 조성물 | |
GB201320959D0 (en) | Compositions | |
GB201315461D0 (en) | Composition of phosphonates |